# FDA Inspection 751820 - Vitalant - October 27, 2011

Source: https://www.keypedia.com/records/fda_inspections/vitalant/5ecca50a-7a68-47bc-a5c3-34565d5095ed
Source feed: FDA_Inspections

> FDA Inspection 751820 for Vitalant on October 27, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 751820
- Company Name: Vitalant
- Inspection Date: 2011-10-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1170860 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/vitalant/8d98bc88-2fa5-4879-be12-dff9f4670a5c)
- [FDA Inspection 1170860 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/vitalant/a1527eef-bf2b-49aa-8d8e-03fe660ca0e6)
- [FDA Inspection 1052734 - 2018-05-11](https://www.keypedia.com/records/fda_inspections/vitalant/1256bb83-f120-4442-90b8-ee6cb6f87c74)
- [FDA Inspection 973311 - 2016-05-24](https://www.keypedia.com/records/fda_inspections/vitalant/b30ac138-fa9f-466a-a165-9ab295942619)
- [FDA Inspection 907143 - 2014-12-15](https://www.keypedia.com/records/fda_inspections/vitalant/34d82ec6-b959-4eac-907a-6aff78c6c08e)

Company: https://www.keypedia.com/companies/vitalant/5059e48c-cf9d-4146-83b3-a3f239b50f02

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d